Cell panel screening

OncoSignature™ standard drug screening service

Identify cells that respond to your therapeutics.

Screen compounds in up to 300 standard cancer cell lines in 2D or 3D formats with OncoSignature. Single agent or combination drug screening available, including 2D long-term assay (10 days).

Custom screening services

Create your own screen specifications.

Benefit from our experience with combination therapeutic screens in complex or different disease type cells.

Preclinical screening platforms for Antibody-Drug Conjugate therapeutics - White Paper

Learn how to systematically evaluate antibody-drug conjugate (ADC) therapeutics through in vitro screening across diverse cell lines is essential for improving therapeutic efficacy and reducing off-target effects.

Learn more now

View our poster to see the benefits of using 3D systems to mimic tumor microenvironments
Read our brochure to learn more about OncoSignature™ and custom cell panel services

First Name *

Last Name *

Email *

Company / Institution Optional

Country *

Zipcode or Postal Code * Optional

Describe your project goal and/or difficulties your are experiencing Optional

By providing my personal data and clicking this button, I acknowledge that Revvity, Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy (available here).*

I would like to stay up-to-date about offers, products and services Optional

Cell panel screening services

Screen in 2D and 3D models, spheroids or organoids.

OncoSignature™ standard drug screening service

Custom screening services

Preclinical screening platforms for Antibody-Drug Conjugate therapeutics - White Paper

Learn more now

Contact us to discuss your next project